{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:22:24Z","timestamp":1792466544982,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR069049"],"award-info":[{"award-number":["R01 AR069049"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bone.2021.115993","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T13:28:40Z","timestamp":1619789320000},"page":"115993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of zeste homolog 2 (Ezh2) accelerate osteoblast differentiation"],"prefix":"10.1016","volume":"150","author":[{"given":"M. Lizeth","family":"Galvan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Paradise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kubrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Khani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Dudakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre J.","family":"van Wijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl","key":"10.1016\/j.bone.2021.115993_bb0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","article-title":"Epidemiology, etiology, and diagnosis of osteoporosis","volume":"194","author":"Lane","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bone.2021.115993_bb0010","series-title":"International Osteoporosis Foundation: The Facts about Osteoporosis and its Impact","author":"Kannus","year":"2003"},{"issue":"4","key":"10.1016\/j.bone.2021.115993_bb0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s001980050224","article-title":"Interim report and recommendations of the World Health Organization task-force for osteoporosis","volume":"10","author":"Genant","year":"1999","journal-title":"Osteoporos. Int."},{"issue":"12","key":"10.1016\/j.bone.2021.115993_bb0020","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bone.2021.115993_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082343","article-title":"Mesenchymal stem cell migration during bone formation and bone diseases therapy","volume":"19","author":"Su","year":"2018","journal-title":"Int J Mol Sci."},{"issue":"6893","key":"10.1016\/j.bone.2021.115993_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature00870","article-title":"Pluripotency of mesenchymal stem cells derived from adult marrow","volume":"418","author":"Jiang","year":"2002","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.bone.2021.115993_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrm3254","article-title":"Building strong bones: molecular regulation of the osteoblast lineage","volume":"13","author":"Long","year":"2011","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"2","key":"10.1016\/j.bone.2021.115993_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41574-019-0282-7","article-title":"A road map for understanding molecular and genetic determinants of osteoporosis","volume":"16","author":"Yang","year":"2020","journal-title":"Nat Rev Endocrinol."},{"key":"10.1016\/j.bone.2021.115993_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/9780470623992.ch2","article-title":"Signal transduction cascades controlling osteoblast differentiation","volume":"7","author":"Krause","year":"2008","journal-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism"},{"issue":"8","key":"10.1016\/j.bone.2021.115993_bb0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat Rev Genet."},{"key":"10.1016\/j.bone.2021.115993_bb0055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bone.2015.03.011","article-title":"Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease","volume":"81","author":"Gordon","year":"2015","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.115993_bb0060","doi-asserted-by":"crossref","unstructured":"van Wijnen AJ, Westendorf JJ. Epigenetics as a new frontier in orthopedic regenerative medicine and oncology. Journal of Orthopaedic Research\u00ae. 2019; 37(7):1465\u201374.","DOI":"10.1002\/jor.24305"},{"issue":"2","key":"10.1016\/j.bone.2021.115993_bb0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s40610-017-0064-8","article-title":"Epigenetic control of osteoblast differentiation by enhancer of zeste homolog 2 (EZH2)","volume":"3","author":"Dudakovic","year":"2017","journal-title":"Current Molecular Biology Reports."},{"key":"10.1016\/j.bone.2021.115993_bb0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bone.2015.03.012","article-title":"Epigenetic histone modifications and master regulators as determinants of context dependent nuclear receptor activity in bone cells","volume":"81","author":"Pike","year":"2015","journal-title":"Bone."},{"issue":"2","key":"10.1016\/j.bone.2021.115993_bb0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11914-013-0143-6","article-title":"MicroRNA functions in osteogenesis and dysfunctions in osteoporosis","volume":"11","author":"van Wijnen","year":"2013","journal-title":"Curr Osteoporos Rep."},{"issue":"4","key":"10.1016\/j.bone.2021.115993_bb0080","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nrendo.2011.234","article-title":"MicroRNA control of bone formation and homeostasis","volume":"8","author":"Lian","year":"2012","journal-title":"Nat Rev Endocrinol."},{"issue":"7621","key":"10.1016\/j.bone.2021.115993_bb0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature19362","article-title":"Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos","volume":"537","author":"Liu","year":"2016","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.bone.2021.115993_bb0090","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cell.2007.02.009","article-title":"Genome regulation by polycomb and trithorax proteins","volume":"128","author":"Schuettengruber","year":"2007","journal-title":"Cell."},{"issue":"34","key":"10.1016\/j.bone.2021.115993_bb0095","doi-asserted-by":"crossref","first-page":"17829","DOI":"10.1074\/jbc.M116.736538","article-title":"Epigenetic plasticity drives Adipogenic and Osteogenic differentiation of marrow-derived Mesenchymal stem cells","volume":"291","author":"Meyer","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bone.2021.115993_bb0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbagrm.2017.01.003","article-title":"Chromatin dynamics regulate mesenchymal stem cell lineage specification and differentiation to osteogenesis","volume":"1860","author":"Wu","year":"2017","journal-title":"Biochim Biophys Acta Gene Regul Mech."},{"issue":"5","key":"10.1016\/j.bone.2021.115993_bb0105","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1002\/jcp.27355","article-title":"Mll-COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2\/p57 in osteoblasts","volume":"234","author":"Rojas","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"47","key":"10.1016\/j.bone.2021.115993_bb0110","doi-asserted-by":"crossref","first-page":"28329","DOI":"10.1074\/jbc.M115.657825","article-title":"Epigenetic control of the bone-master Runx2 gene during osteoblast-lineage commitment by the histone Demethylase JARID1B\/KDM5B","volume":"290","author":"Rojas","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bone.2021.115993_bb0115","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/jcb.25787","article-title":"Histone H4 Methyltransferase Suv420h2 maintains Fidelity of osteoblast differentiation","volume":"118","author":"Khani","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bone.2021.115993_bb0120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2017.01.019","article-title":"Profiling of human epigenetic regulators using a semi-automated real-time qPCR platform validated by next generation sequencing","volume":"609","author":"Dudakovic","year":"2017","journal-title":"Gene."},{"issue":"23","key":"10.1016\/j.bone.2021.115993_bb0125","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1074\/jbc.RA119.011685","article-title":"Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2","volume":"295","author":"Dudakovic","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bone.2021.115993_bb0130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/jbmr.3975","article-title":"\u03b2-Catenin preserves the stem state of murine bone marrow stromal cells through activation of EZH2","volume":"35","author":"Sen","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"49","key":"10.1016\/j.bone.2021.115993_bb0135","doi-asserted-by":"crossref","first-page":"19001","DOI":"10.1074\/jbc.RA118.003909","article-title":"Loss of histone methyltransferase Ezh2 stimulates an osteogenic transcriptional program in chondrocytes but does not affect cartilage development","volume":"293","author":"Camilleri","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.bone.2021.115993_bb0140","doi-asserted-by":"crossref","first-page":"12894","DOI":"10.1074\/jbc.RA118.002983","article-title":"Enhancer of zeste homolog 2 (Ezh2) controls bone formation and cell cycle progression during osteogenesis in mice","volume":"293","author":"Dudakovic","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"47","key":"10.1016\/j.bone.2021.115993_bb0145","doi-asserted-by":"crossref","first-page":"24594","DOI":"10.1074\/jbc.M116.740571","article-title":"Enhancer of Zeste homolog 2 inhibition stimulates bone formation and mitigates bone loss caused by Ovariectomy in skeletally mature mice","volume":"291","author":"Dudakovic","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"46","key":"10.1016\/j.bone.2021.115993_bb0150","doi-asserted-by":"crossref","first-page":"27604","DOI":"10.1074\/jbc.M115.672345","article-title":"Epigenetic control of skeletal development by the histone Methyltransferase Ezh2","volume":"290","author":"Dudakovic","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2021.115993_bb0155","article-title":"Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment","volume":"115659","author":"van Wijnen","year":"2020","journal-title":"Cancer and Development. Bone."},{"key":"10.1016\/j.bone.2021.115993_bb0160","doi-asserted-by":"crossref","first-page":"100027","DOI":"10.1016\/j.gene.2020.100027","article-title":"Mechanical strain-mediated reduction in RANKL expression is associated with RUNX2 and BRD2","volume":"5","author":"Galea","year":"2020","journal-title":"Gene: X."},{"issue":"6","key":"10.1016\/j.bone.2021.115993_bb0165","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1002\/jcp.29415","article-title":"The epigenetic reader Brd4 is required for osteoblast differentiation","volume":"235","author":"Paradise","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bone.2021.115993_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/nar\/gkw826","article-title":"BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire","volume":"45","author":"Najafova","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.bone.2021.115993_bb0175","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/jbmr.3236","article-title":"Histone Deacetylase 3 deletion in Mesenchymal progenitor cells hinders Long bone development","volume":"32","author":"Feigenson","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115993_bb0180","doi-asserted-by":"crossref","unstructured":"Carpio LR, Bradley EW, McGee-Lawrence ME, Weivoda MM, Poston DD, Dudakovic A, et al. Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling. Sci Signal. 2016;9(440):(ra79).","DOI":"10.1126\/scisignal.aaf3273"},{"issue":"40","key":"10.1016\/j.bone.2021.115993_bb0185","doi-asserted-by":"crossref","first-page":"28783","DOI":"10.1074\/jbc.M113.489732","article-title":"Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation","volume":"288","author":"Dudakovic","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bone.2021.115993_bb0190","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/me.2002-0122","article-title":"Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4","volume":"17","author":"Shen","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.bone.2021.115993_bb0195","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4161\/epi.20163","article-title":"DMSO is a strong inducer of DNA hydroxymethylation in pre-osteoblastic MC3T3-E1 cells","volume":"7","author":"Thaler","year":"2012","journal-title":"Epigenetics."},{"issue":"13","key":"10.1016\/j.bone.2021.115993_bb0200","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1074\/jbc.M115.678235","article-title":"Anabolic and Antiresorptive modulation of bone homeostasis by the epigenetic modulator Sulforaphane, a naturally occurring Isothiocyanate","volume":"291","author":"Thaler","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"7330","key":"10.1016\/j.bone.2021.115993_bb0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The Polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","journal-title":"Nature."},{"issue":"21","key":"10.1016\/j.bone.2021.115993_bb0210","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1242\/dev.033902","article-title":"Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice","volume":"136","author":"Schuettengruber","year":"2009","journal-title":"Development."},{"issue":"4","key":"10.1016\/j.bone.2021.115993_bb0215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2008.10.016","article-title":"EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency","volume":"32","author":"Shen","year":"2008","journal-title":"Mol. Cell"},{"issue":"17","key":"10.1016\/j.bone.2021.115993_bb0220","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1242\/dev.063180","article-title":"Ezh2 regulates anteroposterior axis specification and proximodistal axis elongation in the developing limb","volume":"138","author":"Wyngaarden","year":"2011","journal-title":"Development."},{"issue":"4","key":"10.1016\/j.bone.2021.115993_bb0225","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1242\/dev.094342","article-title":"Ezh2 is required for neural crest-derived cartilage and bone formation","volume":"141","author":"Schwarz","year":"2014","journal-title":"Development."},{"issue":"3","key":"10.1016\/j.bone.2021.115993_bb0230","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1096\/fj.201600748R","article-title":"EZH2 deletion in early mesenchyme compromises postnatal bone microarchitecture and structural integrity and accelerates remodeling","volume":"31","author":"Hemming","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2021.115993_bb0235","doi-asserted-by":"crossref","first-page":"13685","DOI":"10.1038\/ncomms13685","article-title":"EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy","volume":"7","author":"Lui","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bone.2021.115993_bb0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ncb2139","article-title":"CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells","volume":"13","author":"Wei","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bone.2021.115993_bb0245","doi-asserted-by":"crossref","first-page":"36988","DOI":"10.1038\/srep36988","article-title":"MiR-101 targets the EZH2\/Wnt\/beta-catenin the pathway to promote the Osteogenic differentiation of human bone marrow-derived Mesenchymal stem cells","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bone.2021.115993_bb0250","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/stem.1573","article-title":"EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification","volume":"32","author":"Hemming","year":"2014","journal-title":"Stem Cells"},{"issue":"39","key":"10.1016\/j.bone.2021.115993_bb0255","doi-asserted-by":"crossref","first-page":"63561","DOI":"10.18632\/oncotarget.11538","article-title":"Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget."},{"issue":"8","key":"10.1016\/j.bone.2021.115993_bb0260","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/stem.2400","article-title":"Enhancer of Zeste homolog 2 and histone Deacetylase 9c regulate age-dependent Mesenchymal stem cell differentiation into osteoblasts and adipocytes","volume":"34","author":"Chen","year":"2016","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.bone.2021.115993_bb0265","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/mt.2015.152","article-title":"Suppression of EZH2 prevents the shift of osteoporotic MSC fate to adipocyte and enhances bone formation during osteoporosis","volume":"24","author":"Jing","year":"2016","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.bone.2021.115993_bb0270","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.4049\/jimmunol.1501466","article-title":"Cutting edge: EZH2 promotes Osteoclastogenesis by epigenetic silencing of the negative regulator IRF8","volume":"196","author":"Fang","year":"2016","journal-title":"J. Immunol."},{"issue":"Pt 2","key":"10.1016\/j.bone.2021.115993_bb0275","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1242\/jcs.114843","article-title":"Ezh2 maintains a key phase of muscle satellite cell expansion but does not regulate terminal differentiation","volume":"126","author":"Woodhouse","year":"2013","journal-title":"J. Cell Sci."},{"issue":"34","key":"10.1016\/j.bone.2021.115993_bb0280","doi-asserted-by":"crossref","first-page":"30071","DOI":"10.1074\/jbc.M111.253518","article-title":"Myocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralization","volume":"286","author":"Stephens","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2021.115993_bb0285","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13578-020-0378-8","article-title":"Control of mesenchymal stem cell biology by histone modifications","volume":"10","author":"Ren","year":"2020","journal-title":"Cell Biosci."},{"issue":"4","key":"10.1016\/j.bone.2021.115993_bb0290","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1073\/pnas.1323226111","article-title":"O-GlcNAcylation regulates EZH2 protein stability and function","volume":"111","author":"Chu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19\u201320","key":"10.1016\/j.bone.2021.115993_bb0295","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1101\/gad.328849.119","article-title":"Regulation of histone methylation by automethylation of PRC2","volume":"33","author":"Wang","year":"2019","journal-title":"Genes Dev."},{"issue":"19\u201320","key":"10.1016\/j.bone.2021.115993_bb0300","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1101\/gad.328773.119","article-title":"Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma","volume":"33","author":"Lee","year":"2019","journal-title":"Genes Dev."},{"issue":"6215","key":"10.1016\/j.bone.2021.115993_bb0305","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1126\/science.1259037","article-title":"An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element","volume":"346","author":"Mansour","year":"2014","journal-title":"Science."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:14:40Z","timestamp":1778940880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221001551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":61,"alternative-id":["S8756328221001551"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.115993","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of zeste homolog 2 (Ezh2) accelerate osteoblast differentiation","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.115993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115993"}}